Is customization available for this product?

Yes, full customization is available from designs and samples.

What are the payment terms?

Payment terms include T/T, LC, and D/P.

What is the lead time for production?

The average lead time is one month for both peak and off-peak seasons.

5ml Vial

Name: GMP Heparin Sodium Injection 40mg/0.4ml - 25000iu/5ml Vial
Brand: Anhui Medipharm Co., Ltd.
SKU: 1978435161

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$2.20-3.70

50,000 vials

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Inject

Model NO.

AMC14085-04

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Injection

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Transport Package

24X0.5ml

Specification

5000IU/5ML, 25000IU/5ML, 1000IU/ML

Trademark

Medipharm, OEM

Origin

China

HS Code

3004909099

Production Capacity

500000 Boxes/Month

Key features

Multiple Dosage Options: Available in 5000IU/5ML, 25000IU/5ML, 1000IU/ML, and other concentrations.

Comprehensive Indications: Used for prophylaxis and treatment of DVT, pulmonary embolism, and myocardial infarction.

Flexible Packaging: Options include 1's, 5's, and 10's per box to suit different needs.

OEM and ODM Services: Full customization available from designs or samples for pharmaceutical partners.

Established Manufacturer: Company established in 2010 with 14 years of export experience and ISO certifications.

Global Market Reach: Exports to South America, Southeast Asia, Middle East, Africa, and South Asia.

Flexible Payment Terms: Accepts T/T, LC, and D/P to accommodate international trade requirements.

Standardized Quality: Manufactured in China with ISO45001:2018 and ISO14001 management system certification.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.16h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.

Product Q&A

Q:What are the main indications for Heparin Sodium Injection?

It is indicated for the prophylaxis and treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris, acute peripheral arterial occlusion, and prophylaxis of mural thrombosis following myocardial infarction.

Q:How should Heparin Sodium Injection be administered?

It can be administered via Intravenous (IV) or Subcutaneous (SC) routes. Dosage varies based on the condition, typically 5,000 units subcutaneously every 8-12 hours for prophylaxis.

Q:What are the common adverse reactions?

Common reactions include erythematous nodules at injection sites and haemorrhage. Haemorrhage is the chief complication, which can be controlled by withdrawing the drug.

Q:Are there specific storage requirements?

No, this medicinal product does not require any special storage conditions before opening.

Q:What is the minimum order quantity?

The minimum order quantity is 1000 pieces.